Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati-781039, India, Phone: +91-361-258 2304; Fax: +91-361-258-2349.
Small. 2013 Oct 25;9(20):3494-505. doi: 10.1002/smll.201203095. Epub 2013 Feb 27.
The fabrication of a versatile nanocarrier based on agglomerated structures of gold nanoparticle (Au NP)-lysozyme (Lyz) in aqueous medium is reported. The carriers exhibit efficient loading capacities for both hydrophilic (doxorubicin) and hydrophobic (pyrene) molecules. The nanocarriers are finally coated with an albumin layer to render them stable and also facilitate their uptake by cancer cells. The interaction between agglomerated structures and the payloads is non-covalent. Cell viability assay in vitro showed that the nanocarriers by themselves are non-cytotoxic, whereas the doxorubicin-loaded ones are cytotoxic, with efficiencies higher than that of the free drug. Transmission electron microscopy and fluorescence microscopy along with flow cytometry analysis confirm the uptake of the drug-loaded nanocarriers by a human cervical cancer HeLa cell line. Field-emission scanning electron microscopy reveals the formation of apoptotic bodies leading to cell death, confirming the release of the payloads from the nanocarriers into the cell. Overall, the findings suggest the fabrication of novel Au NP-protein agglomerate-based nanocarriers with efficient drug-loading and -releasing capabilities, enabling them to act as multimodal drug-delivery vehicles.
本文报道了一种基于金纳米粒子(Au NP)-溶菌酶(Lyz)聚集结构在水介质中制备多功能纳米载体的方法。该载体对亲水性(阿霉素)和疏水性(芘)分子均具有高效的负载能力。最后,纳米载体用白蛋白层进行包覆,以使其稳定,并促进其被癌细胞摄取。聚集结构与有效载荷之间的相互作用是非共价的。体外细胞活力测定表明,纳米载体本身无细胞毒性,而载药的纳米载体则具有细胞毒性,其效率高于游离药物。透射电子显微镜、荧光显微镜和流式细胞术分析证实了载药纳米载体被人宫颈癌细胞系 HeLa 的摄取。场发射扫描电子显微镜揭示了导致细胞死亡的凋亡小体的形成,证实了有效载荷从纳米载体中释放到细胞中。总的来说,这些发现表明可以制备新型基于 Au NP-蛋白质聚集体的纳米载体,具有高效的药物负载和释放能力,使其能够作为多模式药物递送载体。